May 25, 2023 / 09:30AM GMT
Operator
Ladies and gentlemen, good day and welcome to the Q4 FY23 earnings call of JB Pharma as on the May 25, 2023. (Operator Instructions) Please note this conference call is being recorded.
I now hand the conference over to Mr. Jason D'souza, Vice President at JP Pharma. Thank you and over to you, sir.
Jason D'souza - J.B. Chemicals & Pharmaceuticals Ltd. - VP, IR
Thank you, Bekam. Welcome to the earnings call of JB Pharma. We have with us today, Nikhil Chopra, CEO and Whole Time Director; Mr. Kunal Khanna, President, Operation; and Mr. Lakshay Kataria, Chief Financial Officer of J.B. Chemicals and Pharmaceuticals Limited.
Before we begin, I would like to state that some of the statements in today's discussion may be forward looking in nature and may involve certain risks and uncertainties. Our detailed statement in this regard is available on the Q4 FY23 results presentation that has been sent to you earlier.
I would like to hand over the floor to Mr. Nikhil Chopra to begin the proceedings of the call with his
Q4 2023 J B Chemicals and Pharmaceuticals Ltd Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot